Ocular microvasculature tone modulation

Ocular microvasculature tone modulation" is not a specific molecule or receptor but rather describes the physiological process by which the tone (constriction or dilation) of small blood vessels in the eye is regulated. This process involves multiple molecular pathways and cell types, including endothelial cells, smooth muscle cells, and perivascular nerves. Key mediators include nitric oxide synthases (especially eNOS and nNOS), which produce nitric oxide to induce vasodilation; vasoactive peptides such as endothelin for vasoconstriction; and purines like adenosine for vasodilation. These mechanisms are essential for maintaining proper ocular blood flow and homeostasis, with dysregulation implicated in diseases such as diabetic retinopathy[2][3][4]. Because "ocular microvasculature tone modulation" refers to a complex physiological function rather than a discrete druggable target or protein entity, it should not be classified as a canonical therapeutic target.

Vasodilation via nitric oxide synthase activation (eNOS, nNOS)[2][3]; Vasoconstriction via endothelin signaling[4]